The health risk information presented here is summarized from Shoreland Travax®, a decision-support tool used by health care providers to perform a detailed health risk analysis based on specific locations, individual travel styles, and traveler risk behaviors. Travax provides practitioners current, independently researched malaria risk and prevention recommendations in a map-based format that goes beyond the annual WHO and US CDC statements included here. Not included here are current reports from Travax of disease outbreaks or environmental events that may pose elevated risks to travelers’ health and safety. The Providers section of this site offers a directory of health care providers who utilize Shoreland Travax for travel health counseling. Learn more about the detailed reports and maps available from these practitioners (includes links to samples).
See also: COVID-19 Traveler Summary
Fully vaccinated: 7.4%
Daily new cases: 20 (7-day rolling average)
Daily new cases / 100,000: 0.1
Daily new deaths: < 1 (7-day rolling average)
Daily new deaths / 100,000: 0.002
Persons not up-to-date on COVID-19 vaccinations should avoid travel to this country; risk is unknown. Persons who are at increased risk for severe illness from COVID-19 (even if up-to-date on COVID-19 vaccinations) should seek informed medical advice and consider delaying travel. All travelers should be up-to-date prior to their trip and follow destination requirements and recommendations. All persons aged ≥ 2 years should wear a well-fitting mask in indoor public spaces.
Burkina Faso is a developing nation classified as low income. Located in western Africa (north of Ghana and south of Mali), the climate is classified as dry (semi arid).
See also: Library article for Yellow Fever
- Requirement: A vaccination certificate is required for all travelers aged ≥ 9 months.
- Official Status: listed by WHO as a country where YF transmission risk is present.
Depending on your itinerary, your personal risk factors, and the length of your visit, your health care provider may offer you vaccination against hepatitis A, hepatitis B, influenza, measles, mumps, rubella, meningococcal meningitis, rabies, typhoid fever, or a one time polio booster if you haven't previously received one for travel. Routine immunizations, such as those that prevent tetanus/diphtheria or "childhood" diseases, should be reviewed and updated as needed.
See also: Library article for Malaria
The following is current information as reported by the World Health Organization (WHO) and the US Centers for Disease Control (CDC):
WHO—International Travel and Health (current online update, Country List)(2020) Malaria risk due predominantly to P. falciparum exists throughout the year in the entire country.
- Recommended prevention: C – Risk of P. falciparum malaria, in combination with reported chloroquine and sulfadoxine–pyrimethamine resistance. Mosquito bite prevention plus atovaquone–proguanil or doxycycline or mefloquine chemoprophylaxis (select according to reported side effects and contraindications) a
aAlternatively, for travel to rural areas with low risk of malaria infection, mosquito bite prevention can be combined with stand–by emergency treatment (SBET).
WHO Country List footnote: When available, the date of the most recent update or confirmation is indicated in parentheses in the country list. If no date is indicated, the most recent update or confirmation was provided before 2013.
CDC—Health Information for International Travel (current online edition)Areas with malaria: All.
- Drug resistance3 : Chloroquine.
- Malaria species: P. falciparum >80%, P. ovale 5%–10%, P. vivax rare.
- Recommended chemoprophylaxis: Atovaquone-proguanil, doxycycline, mefloquine, or tafenoquine.4
3 Refers to P. falciparum malaria unless otherwise noted.
4 Primaquine and tafenoquine can cause hemolytic anemia in people with G6PD deficiency. Patients must be screened for G6PD deficiency before starting primaquine or tafenoquine. See Tafenoquine Approved for Malaria Prophylaxis and Treatment for more information.
See also: Library article for Travelers' Diarrhea
High risk exists throughout the country, including in deluxe accommodations. Food and beverage precautions may reduce the likelihood of illness.
Travelers should carry loperamide for self-treatment of diarrhea and, if risk is moderate to high, an antibiotic to add if diarrhea is severe. Consult a knowledgeable health care provider regarding which antibiotic is appropriate for you and most effective for your destination.
Insect- and Arthropod-Borne Diseases
Other Disease and Health Risks
The material below includes information from the US Department of State (DOS), the UK Foreign, Commonwealth & Development Office (FCO), Global Affairs Canada (GAC), and Australia's Department of Foreign Affairs and Trade (DFAT), as well as from additional open-source material. Standard safety precautions that apply to all international travel can be found in the Library article Safety and Security.
Consular Travel Advice
Due to terrorism, violent crime, and other ongoing security concerns, US (DOS), Canada (GAC), and Australia (DFAT) advise avoiding all travel to this country. UK (FCO) has a more limited warning.
High risk of attack by domestic and/or transnational terrorist groups exists throughout the country, especially in Ouagadougou. Targets may include domestic and international organizations and businesses; public places and events, including those frequented by tourists; and transportation systems.
Since 2016, attacks have targeted areas frequented by tourists in Ouagadougou, including hotels and restaurants.
High risk of kidnapping by terrorist groups exists throughout the country, especially in northern and southwestern areas and in areas bordering Niger and Benin. Targets may include foreigners (especially Westerners), journalists, nongovernmental organization workers, missionaries, and aid workers.
Moderate risk of violent crime (armed robbery and carjacking) exists throughout the country, mainly in remote and border areas, in Bobo-Dioulasso and Ouagadougou, and on major roads.
High risk of petty crime exists in cities, especially in Ouagadougou (particularly around the Christmas holidays and during festivals) and in areas surrounding the UN traffic circle and Central Market.
Theft of valuables from unattended accommodations is common.
Scams involving gems and precious metals have been reported.
Protests and demonstrations occur throughout the country and are generally peaceful but have the potential to turn violent without warning. Bystanders are at risk of harm from violence or from the response by authorities. Disruption to transportation, free movement, or the ability to carry out daily activities may occur.
A dangerous security environment may exist in areas bordering Mali, Niger, Benin, and Togo.
Significant risk of traffic-related injury or death exists. The road traffic death rate is more than 24 per 100,000 population, the highest risk category. Carefully assess the safety of transportation options before any road travel.
Structural standards for vehicles may not meet international standards.
The rainy season is from June through October. Floods, mudslides, and landslides may occur.
Sandstorms and dust storms occur from February through June.
Selected Embassies or Consulates in Burkina Faso
- United States: [+226] 25-49-53-00; bf.usembassy.gov
- Canada: [+226] 25-49-08-00; www.burkinafaso.gc.ca
- United Kingdom: U.K. does not have an embassy or consulate in Burkina Faso.
- Australia: Australia does not have an embassy or consulate in Burkina Faso.
Burkina Faso's Embassies or Consulates in Selected Countries
- In the U.S.: www.burkina-usa.org
- In Canada: ambabf-ca.org/home-en
- In the U.K.: Burkina Faso does not have an embassy or consulate in the U.K.
- In Australia: Burkina Faso does not have an embassy or consulate in Australia.
HIV testing is not required to obtain a tourist, work, or residence visa.